Literature DB >> 21253876

The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?

Timothy M Pawlik1, David Cosgrove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21253876      PMCID： PMC3547619          DOI： 10.1007/s11605-011-1423-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  38 in total

1.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Authors:  Jean-Nicolas Vauthey; Timothy M Pawlik; Dario Ribero; Tsung-Teh Wu; Daria Zorzi; Paulo M Hoff; Henry Q Xiong; Cathy Eng; Gregory Y Lauwers; Mari Mino-Kenudson; Mauro Risio; Andrea Muratore; Lorenzo Capussotti; Steven A Curley; Eddie K Abdalla
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

2.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

3.  Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.

Authors:  Pasquale Comella; Donato Natale; Antonio Farris; Antonio Gambardella; Luigi Maiorino; Bruno Massidda; Rossana Casaretti; Salvatore Tafuto; Vito Lorusso; Silvana Leo; Michele Cannone
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

4.  Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver.

Authors:  M J O'Connell; M A Adson; A J Schutt; J Rubin; C G Moertel; D M Ilstrup
Journal:  Mayo Clin Proc       Date:  1985-08       Impact factor: 7.616

5.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

6.  FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors:  Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

7.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

8.  Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.

Authors:  P Thirion; S Michiels; J P Pignon; M Buyse; A C Braud; R W Carlson; M O'Connell; P Sargent; P Piedbois
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
View more
  5 in total

1.  SSAT/AHPBA Joint Symposium: Today's approaches to colorectal cancer (CRC) liver metastases.

Authors:  W Scott Helton
Journal:  J Gastrointest Surg       Date:  2011-02-01       Impact factor: 3.452

2.  Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis.

Authors:  Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; David Cosgrove; Darren Cowzer; Umberto Cillo; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-16       Impact factor: 3.452

3.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

Review 4.  HER2-positive gastric cancer.

Authors:  Narikazu Boku
Journal:  Gastric Cancer       Date:  2013-04-07       Impact factor: 7.370

5.  Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Authors:  Dexiang Zhu; Yunshi Zhong; Ye Wei; Lechi Ye; Qi Lin; Li Ren; Qinghai Ye; Tianshu Liu; Jianmin Xu; Xinyu Qin
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.